Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ICICI Pru Nifty Healthcare ETF
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.17.784315766225.1361
Domestic EquitiesCipla Ltd.8.95018414812.6500
Domestic EquitiesMAX Healthcare Institute Ltd8.770711120812.3964
Domestic EquitiesApollo Hospitals Enterprise Ltd.7.92331511511.1987
Domestic EquitiesDr. Reddy's Laboratories Ltd.7.89139114511.1534
Domestic EquitiesDivi's Laboratories Ltd.7.64961900310.8118
Domestic EquitiesFortis Healthcare Ltd.5.3495779637.5609
Domestic EquitiesLupin Ltd.4.8943361936.9176
Domestic EquitiesTorrent Pharmaceuticals Ltd.3.9889156475.6379
Domestic EquitiesLaurus Labs Ltd.3.4618581244.8929
Domestic EquitiesAlkem Laboratories Ltd.3.233484244.5700
Domestic EquitiesAurobindo Pharma Ltd.3.2086418404.5350
Domestic EquitiesGlenmark Pharmaceuticals Ltd.3.1125225294.3992
Domestic EquitiesMankind Pharma Ltd.2.9151169164.1202
Domestic EquitiesZydus Lifesciences Ltd.2.5961373693.6693
Domestic EquitiesBiocon Ltd.2.1680898603.0642
Domestic EquitiesIPCA Laboratories Ltd.1.9699207932.7842
Domestic EquitiesAbbott India Ltd.1.61647802.2846
Domestic EquitiesSyngene International Ltd.1.2505283761.7674
Domestic EquitiesPiramal Pharma Ltd.1.2505924541.7674
Total 99.9849 141.3172
Cash & Cash Equivalents and Net AssetsNet Current Assets0.0116 0.0163
Cash & Cash Equivalents and Net AssetsTREPS0.0035 0.0050
Total 0.0151 0.0213
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.